Rankings
▼
Calendar
BLTE Q2 2025 Earnings — Belite Bio, Inc Revenue & Financial Results | Market Cap Arena
BLTE
Belite Bio, Inc
$7B
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$18M
Net Income
-$16M
EPS (Diluted)
$-0.50
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
$0
Free Cash Flow
$0
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$156M
Total Liabilities
$7M
Stockholders' Equity
$150M
Cash & Equivalents
$0
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$18M
-$10M
-68.0%
Net Income
-$16M
-$9M
-71.9%
← FY 2025
All Quarters
Q3 2025 →